Nucleic Acid Labeling Market Analysis

Product Type (Reagents, Kits)

The global nucleic acid labeling market is segmented and analyzed for demand and supply by product type into reagents, and kits. Among these segments, the kits segment is anticipated to capture the largest market size in the global nucleic acid labeling market. The growing application of DNA labeling and detection products for detection and purification is expected to drive segment growth during the forecast period. Moreover, the surge in cases of COVID-19 along with the development of advanced labeling kits by key manufacturers for COVID- 19 diagnostics, is further anticipated to fuel segment growth. For instance, Perkin Elmer Inc's new COVID-19 nucleic acid detection kit is an in vitro real-time RT-PCR diagnostic kit for detecting nucleic acid from SARS-CoV-2 in humans with 48 tests included in the kit. The kits help to avoid long waiting times in lines at hospitals and the risk of infections is more in health facilities. The home-tested kits also help to prevent traveling chargers. Even health professionals will save time as everything is assembled in the kit which is disposable after use.

Application (DNA sequencing, PCR, FISH,Microarray, In Situ Hybridization, Blotting)

The global nucleic acid labeling market is also segmented and analyzed for demand and supply by application into DNA sequencing, PCR, FISH, microarray, In situ hybridization, botting, and others. The In-situ hybridization segment is estimated to garner the largest share. The rising prevalence of genetic disorders and increasing use of In-situ hybridization in the manufacturing of cancer and genetic disorder drugs or medicines. The increasing growth of infections among people as well as research and development funds to improve the market segment growth is estimated to drive the growth of the market. It is also used to understand the disease such as the DNA or chromosomal abnormalities that cause the disorder. Rising pharmaceutical, diagnostic, and biopharmaceutical companies boost the growth of the segment. As per the estimations of the World Health Organization, about 10 in 1000 people are affected by the monogenic disease across the world.

Our in-depth analysis of the global market includes the following segments: